ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
83 960,92
0,00%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Regeneron Pharmaceuticals Inc (REGN) Cours

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc (REGN)

NASDAQ
666,87
-13,74
(-2,02%)
Fermé 15 Mars 9:00PM
Retardé de 15 minutes
665,6222
-1,25
(-0,19%)
Après les heures de négociation: 12:58AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
665,6222
Prix Achat
662,00
Prix Vente
680,00
Volume échangé
1 306 090
657,00 Fourchette du Jour 686,98
642,00 Plage de 52 semaines 1 211,1999
Cap du marché
72,769B
Clôture Veille
680,61
Ouverture
680,61
Dernière Transaction
2
@
666.6
Dernière heure de transaction
Volume financier
US$ 874 150 873
VWAP
669,2884
Volume moyen (3 m)
911 767
Actions en circulation
109 324 682
Rendement du Dividende
0.53%
Ratio Cours sur Bénéfices
16,52
Bénéfice par action (BPA)
40,36
Chiffre d'affairess
14,2B
Bénéfice net
4,41B

À propos de Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL ... Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. Show more

Secteur
Pharmaceutical Preparations
Industrie
Health Care Diversified
Site Web
www.regeneron.com
Siège social
New York, New York, USA
Fondé
1988
Regeneron Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker REGN. Le dernier cours de clôture d'Regeneron Pharmaceuticals était de US$680,61. Au cours de la dernière année, les actions de Regeneron Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 642,00 à US$ 1 211,1999.

Regeneron Pharmaceuticals compte actuellement 109 324 682 actions en circulation. La capitalisation boursière d'Regeneron Pharmaceuticals est de US$74,41 milliard. Regeneron Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de 16.52.

Flux d'options Regeneron Pharmaceuticals (REGN)

Voir le flux d'options complet

Flux global

Haussier

Prime nette

278k

Calls / Puts

133.33%

Ach. / Vent.

42.86%

OTM / ITM

110.00%

Sweeps Ratio

0.00%

REGN Dernières nouvelles

Plus de nouvelles
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-33.0078-4.72464680875698.63748.29665.62221098106713.83563724CS
4-12.5778-1.85458566794678.2748.29665.6222882993701.28416569CS
12-44.5778-6.27679526894710.2748.29642911767698.36970903CS
26-496.4278-42.72000344221162.051165.85642855503792.92458258CS
52-300.6778-31.1164027735966.31211.1999642649702875.33496509CS
15621.02223.26127831213644.61211.1999538.01623656790.70998079CS
260213.112247.0955779983452.511211.1999424.01745624674.98130413CS

REGN - Frequently Asked Questions (FAQ)

What is the current Regeneron Pharmaceuticals share price?
The current share price of Regeneron Pharmaceuticals is US$ 665,6222
How many Regeneron Pharmaceuticals shares are in issue?
Regeneron Pharmaceuticals has 109 324 682 shares in issue
What is the market cap of Regeneron Pharmaceuticals?
The market capitalisation of Regeneron Pharmaceuticals is USD 74,41B
What is the 1 year trading range for Regeneron Pharmaceuticals share price?
Regeneron Pharmaceuticals has traded in the range of US$ 642,00 to US$ 1 211,1999 during the past year
What is the PE ratio of Regeneron Pharmaceuticals?
The price to earnings ratio of Regeneron Pharmaceuticals is 16,52
What is the cash to sales ratio of Regeneron Pharmaceuticals?
The cash to sales ratio of Regeneron Pharmaceuticals is 5,13
What is the reporting currency for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Regeneron Pharmaceuticals?
The latest annual turnover of Regeneron Pharmaceuticals is USD 14,2B
What is the latest annual profit for Regeneron Pharmaceuticals?
The latest annual profit of Regeneron Pharmaceuticals is USD 4,41B
What is the registered address of Regeneron Pharmaceuticals?
The registered address for Regeneron Pharmaceuticals is 28 LIBERTY STREET, NEW YORK, NEW YORK, 10005
What is the Regeneron Pharmaceuticals website address?
The website address for Regeneron Pharmaceuticals is www.regeneron.com
Which industry sector does Regeneron Pharmaceuticals operate in?
Regeneron Pharmaceuticals operates in the HEALTH CARE DIVERSIFIED sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
REGN
Regeneron Pharmaceuticals
NASDAQ
ATER
Aterian
USOTC
MYLKF
Planting Hope (CE)
NASDAQ
JOAN
JOANN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces